• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    S

    Saint Louis University School of Medicine

    院校medschool.slu.edu
    408论文总数
    9,850引用总数

    Saint Louis University School of Medicine (SLUSOM) is a private, American Medical School within Saint Louis University. Located in the city of St. Louis, Missouri, Saint Louis University School of Medicine was established in 1836 and has the distinction of awarding the first M.D. degree west of the Mississippi River.The school comprises about 700 medical students, 550 faculty members and 550 residents in 48 graduate medical education programs including residencies, subspecialty residencies and fellowships. The School is a pioneer in geriatric medicine, chronic disease prevention, cardiovascular disease, organ transplantation, neurosciences and vaccine research among others. It is a leading center of research in five key areas: cancer, infectious disease, liver disease, aging and brain disorders, and heart/lung disease. It provides health services on a local, national, and international level while conducting medical research and training physicians and biomedical scientists of the future. Cardinal Glennon Children's Hospital and Saint Louis University Hospital are the two main affiliated teaching hospitals of the school.

    论文量&引用量时间轴

    机构学者

    论文(408)

    年份
    起
    –
    止
    排序
    1Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular Treatments.
    Rafael José Vieira,Bernardo Sousa-Pinto,Jean Bousquet, Holger J Schünemann,Torsten Zuberbier,Antonio Bognanni,Alkis Togias,Boleslaw Samolinski,Arunas Valiulis,Sian Williams,Anna Bedbrook,Wienczyslawa Czarlewski,

    BACKGROUND:Oral and ocular medications are frequently used in the treatment of allergic rhinitis (AR). As part of the update of the Allergic Rhinitis and its Impact on Asthma (ARIA)-EAACI guidelines, this manuscript presents the ARIA-EAACI 2024-2025 recommendations for oral and ocular treatments. METHODS:The ARIA-EAACI 2024-2025 guideline panel issued recommendations following the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) evidence-to-decision framework. Several sources of evidence were used to inform panel judgements and recommendations, including systematic reviews, mHealth and pharmacovigilance data as well as a survey on costs. RESULTS:Eight guideline questions concerning oral treatments for AR and three questions concerning ocular treatments were addressed. These questions led to the recommendations. Overall, these questions concern the choice between different classes of medication. They also discuss the role of oral antihistamines (OAH), leukotriene receptor antagonists (LTRA), ocular antihistamines (OcAH) and ocular mast cell stabilisers. Four questions had not been previously evaluated in ARIA guidelines, while, for the other four, there was a change in the strength or directionality of the recommendations. Overall, these guidelines recommend using intranasal corticosteroids over OAH and using OAH over LTRA. Moreover, they suggest using OAH over OcAH and suggest being against adding LTRA to OAH. Finally, considerations for choosing between different individual OAHs are presented. CONCLUSION:This ARIA-EAACI 2024-2025 article supports patients, their caregivers and healthcare professionals in choosing oral and ocular treatments for AR. Decisions on treatment should consider the clinical variability of the disease, patients' values and the affordability of medications.

    2026Allergy(2026)引用:3
    引用
    AI阅读
    加入学术空间
    2Immunodeficiency-associated Primary CNS Lymphomas: an International Primary CNS Lymphoma Collaborative Group Study.
    Leon D Kaulen,Lakshmi Nayak,Philipp Karschnia,Imke Kraai,Daniela Galluzzo,Fleur A de Groot, Matthew Witterholt,Laura Donovan,Sita Bhella, Luis P Kuschel,Christopher P Fox,Sabine Seidel,

    ABSTRACT:Immunodeficiency-associated primary central nervous system lymphoma (ID-PCNSL) represents a clinicopathologically distinct PCNSL subtype, for which large studies and prognostic models are lacking. To address this gap, the International PCNSL Collaborative Group conducted a retrospective multicenter study, integrating clinical, radiological, and pathological data from 308 ID-PCNSL cases, diagnosed at 23 participating sites in 7 countries. Preexisting immunodeficiency included administration of immunosuppressants for transplantation (41.2%) or autoimmunity (36.7%) and HIV infection (21.7%). All tumors were diffuse large B-cell lymphomas, with Epstein-Barr virus (EBV) detected in 79.2%. Immune reconstitution together with rituximab and methotrexate-based chemotherapy was associated with the highest response rates and prolonged progression-free survival, irrespective of immunodeficiency subtype and EBV status. Survival outcomes were highly variable, with a 54-month median overall survival. Multivariable Cox regression identified age (per year increment; hazard ratio [HR], 1.05 (95% confidence interval [CI], 1.02-1.07); P< .001), Karnofsky performance status (KPS) <70 (HR, 3.10; 95% CI, 1.67-5.87; P< .001), and EBV positivity (HR, 3.26; 95% CI, 1.47-7.33; P = .004) as prognostic factors for overall survival. A prognostic score was developed based on the sum of these adverse variables (age >60 years, KPS <70, EBV positivity). Stratification by this score yielded median survival times of 135, 29, and 3 months in patients with up to 1, 2, and 3 unfavorable markers (P< .0001). It allowed improved prognostic stratification of ID-PCNSL as compared with the Memorial Sloan Kettering Cancer Center and International Extranodal Lymphoma Study Group models developed for immunocompetent PCNSL. Collectively, this large international cohort defines clinicobiological features of ID-PCNSL and introduces a prognostic system with potential to guide future management.

    2026Blood(2026)引用:3
    引用
    AI阅读
    加入学术空间
    3Surgeons' Contribution to Japanese Anesthesiology.
    Shigemasa Ikeda

    The Japanese Museum of Anesthesiology states that Dr. Michinosuke Amano published the first Japanese textbook of anesthesiology in 1953. Dr. Amano completed formal anesthesiology training at the University of Chicago in 1952 as a Government Account for Relief in Occupied Areas (GARIOA) scholar and published his textbook the following year. His book was undoubtedly the first Japanese anesthesiology textbook authored by a fully trained anesthesiologist. Until anesthesiology was established as an independent medical specialty in the 1950s, anesthesia was typically administered by surgeons. Their knowledge of anesthetic practice was largely acquired through chapters on anesthesia in general surgery textbooks. However, a book devoted entirely to anesthesiology was published in 1940 by Dr. Seiji Tsuda, then Professor of Surgery at Okayama Medical College. His book was revised in 1947 and 1957. Although Prof. Tsuda was not trained as an anesthesiologist, his books marked an important step toward recognizing anesthesiology as a distinct specialty. This manuscript reviews Prof. Tsuda's 1940 book and its subsequent revisions, and discusses their historical significance as foundational contributions to Japanese anesthesiology at a time when the specialty had not yet emerged as an independent discipline.

    2026Journal of Anesthesia(2026)引用:1
    引用
    AI阅读
    加入学术空间
    4Successful Hematopoietic Progenitor Cell Collections Using Fenestrated Peripheral Catheters: Safety, Performance, and Engraftment Outcomes in a Case Series.
    Nehemias Guevara Rodriguez, Ziniya Shah, Mohamed M Khamis, Maureen Brummet, Ranju Kunwor, Aleksander Babic
    2026Transfusion and apheresis science official journal of the World Apheresis Association official jou...(2026)
    引用
    AI阅读
    加入学术空间
    5Implications of Cuts to Federal Research Funding for Plastic Surgery
    Atharva M Bhagwat, Rohun Gupta, Alex J Reiter, Kevin Chen,Aladdin H Hassanein, Brian A Mailey
    2026Plastic and reconstructive surgery Global open(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 408 篇论文

    合作机构(100)

    圣路易斯大学合作论文 44
    University of Washington School of Medicine合作论文 23
    华盛顿大学合作论文 23
    圣路易斯华盛顿大学合作论文 18
    Washington University School of Medicine合作论文 14
    梅奥诊所合作论文 13
    加州大学合作论文 9
    Saint Louis University Hospital,SSM Health Care合作论文 8
    哥伦比亚大学合作论文 8
    The University of Texas Southwestern Medical Center,The University of Texas System合作论文 8

    机构统计